» Articles » PMID: 19554194

Particulate Matter Air Pollution Exposure: Role in the Development and Exacerbation of Chronic Obstructive Pulmonary Disease

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2009 Jun 26
PMID 19554194
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Due to the rapid urbanization of the world population, a better understanding of the detrimental effects of exposure to urban air pollution on chronic lung disease is necessary. Strong epidemiological evidence suggests that exposure to particulate matter (PM) air pollution causes exacerbations of pre-existing lung conditions, such as, chronic obstructive pulmonary disease (COPD) resulting in increased morbidity and mortality. However, little is known whether a chronic, low-grade exposure to ambient PM can cause the development and progression of COPD. The deposition of PM in the respiratory tract depends predominantly on the size of the particles, with larger particles deposited in the upper and larger airways and smaller particles penetrating deep into the alveolar spaces. Ineffective clearance of this PM from the airways could cause particle retention in lung tissues, resulting in a chronic, low-grade inflammatory response that may be pathogenetically important in both the exacerbation, as well as, the progression of lung disease. This review focuses on the adverse effects of exposure to ambient PM air pollution on the exacerbation, progression, and development of COPD.

Citing Articles

Chitosan Nanoparticle-Encapsulated Grown on Germinated Reduces Type II Alveolar Epithelial Cell Apoptosis in PM-Induced Lung Injury.

Kim H, Kim J, Park B, Park H Int J Mol Sci. 2025; 26(3).

PMID: 39940873 PMC: 11817496. DOI: 10.3390/ijms26031105.


Lam. Extract Alleviates Airway Inflammation Induced by Particulate Matter Plus Diesel Exhaust Particles in Mice.

Sung Y, Kim S, Yang W, Yuk H, Kim M, Kim D Nutrients. 2024; 16(21).

PMID: 39519565 PMC: 11547324. DOI: 10.3390/nu16213732.


Exploring the association between ambient air pollution and COVID-19 risk: A comprehensive meta-analysis with meta-regression modelling.

Musonye H, He Y, Bekele M, Jiang L, Cao F, Xu Y Heliyon. 2024; 10(12):e32385.

PMID: 39183866 PMC: 11341291. DOI: 10.1016/j.heliyon.2024.e32385.


Association of Fine Particulate Matter and Residential Greenness With Risk of Pulmonary Tuberculosis Retreatment: Population-Based Retrospective Study.

Guo T, Shen F, Xin H, Du J, Cao X, Feng B JMIR Public Health Surveill. 2024; 10:e50244.

PMID: 39140280 PMC: 11337066. DOI: 10.2196/50244.


Metal(loid) bioaccessibility and risk assessment of ashfall deposit from Popocatépetl volcano, Mexico.

Schiavo B, Meza-Figueroa D, Morton-Bermea O, Angulo-Molina A, Gonzalez-Grijalva B, Armienta-Hernandez M Environ Geochem Health. 2024; 46(9):354.

PMID: 39080128 PMC: 11289158. DOI: 10.1007/s10653-024-02135-8.


References
1.
Bouhuys A, Beck G, Schoenberg J . Do present levels of air pollution outdoors affect respiratory health?. Nature. 1978; 276(5687):466-71. DOI: 10.1038/276466a0. View

2.
Torres-Duque C, Maldonado D, Perez-Padilla R, Ezzati M, Viegi G . Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc. 2008; 5(5):577-90. DOI: 10.1513/pats.200707-100RP. View

3.
van Eeden S, Tan W, Suwa T, Mukae H, Terashima T, Fujii T . Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med. 2001; 164(5):826-30. DOI: 10.1164/ajrccm.164.5.2010160. View

4.
Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies W, Hogg J . Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis. 1992; 146(1):177-84. DOI: 10.1164/ajrccm/146.1.177. View

5.
Zhou H, Kobzik L . Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2006; 36(4):460-5. PMC: 1899326. DOI: 10.1165/rcmb.2006-0293OC. View